IDEAYA Biosciences Receives Orphan Drug Designation for Darovasertib, a PKC Inhibitor, for the Treatment of Uveal Melanoma

May 2, 2022

Biotechnology

Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus(TM)

September 15, 2026
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics

September 15, 2026
Evaxion applies its AI-Immunology(TM) platform in autoimmune diseases

September 14, 2026
Tempest Therapeutics Announces Up to $7.5 Million Private Placement

September 11, 2026